A novel in vitro cell model of the proteinase/antiproteinase balance observed in alpha-1 antitrypsin deficiency

Background: Alpha-1 antitrypsin deficiency (AATD) is a genetic condition resulting from mutations in the alpha-1 antitrypsin (AAT) protein, a major systemic antiproteinase, resulting in reduced/no release of AAT, disrupting the proteinase/antiproteinase balance. A sustained imbalance can cause struc...

Full description

Bibliographic Details
Published in:	Frontiers in Pharmacology
Main Authors:	Celine H. Chen, Helena Crisford, Aaron Scott, Elizabeth Sapey, Robert A. Stockley
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-07-01
Subjects:	neutrophil elastase proteinase 3 proof of concept MPH966 alpha-1 antitrypsin deficiency
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1421598/full

Similar Items

Assessing the efficacy of Alpha1-Proteinase inhibitor (human) augmentation therapy for Alpha1-Antitrypsin deficiency – Related emphysema: Challenges and opportunities
by: L. Ross Pierce
Published: (2024-06-01)

C3d Elicits Neutrophil Degranulation and Decreases Endothelial Cell Migration, with Implications for Patients with Alpha-1 Antitrypsin Deficiency
by: Laura T. Fee, et al.
Published: (2021-12-01)

Alpha-1 antitrypsin deficiency-associated panniculitis: a case report
by: Špela But, et al.
Published: (2025-06-01)

Expert Perspectives on the Management of Alpha 1-Antitrypsin Deficiency
by: Bebiana Conde, et al.
Published: (2022-07-01)

The prevalence of bronchiectasis in patients with alpha-1 antitrypsin deficiency: initial report of EARCO
by: Robert A. Stockley, et al.
Published: (2023-08-01)

Alpha-1 Antitrypsin Augmentation Inhibits Proteolysis of Neutrophil Membrane Voltage-Gated Proton Channel-1 in Alpha-1 Deficient Individuals
by: Padraig Hawkins, et al.
Published: (2021-08-01)

Decrease in alpha-1 antiproteinase antitrypsin is observed in primary Sjogren’s syndrome condition
by: Brij B. Singh, et al.
Published: (2020-07-01)

Changes in the Expression of Insulin Pathway, Neutrophil Elastase and Alpha 1 Antitrypsin Genes from Leukocytes of Young Individuals with Insulin Resistance
by: Cruz-Pineda WD, et al.
Published: (2022-06-01)

PROINFLAMMATORY CYTOKINE PROFILE IN PATIENTS WITH DIFFERENT ALPHA-1-ANTITRYPSIN PHENOTYPES
by: M. Yu. Pervakova, et al.
Published: (2016-12-01)

Cardiovascular disease in Alpha 1 antitrypsin deficiency: an observational study assessing the role of neutrophil proteinase activity and the suitability of validated screening tools
by: E. Sapey, et al.
Published: (2024-03-01)

The Alpha 1 antitrypsin deficiency - etiology, symptoms in various organs, diagnosis, treatment, prognosis
by: Dawid Kościołek, et al.
Published: (2024-02-01)

The impact of diagnostic delay on survival in alpha-1-antitrypsin deficiency: results from the Austrian Alpha-1 Lung Registry
by: Tobias Meischl, et al.
Published: (2023-01-01)

High BMI and COPD Outcomes in Alpha-1 Antitrypsin DeficiencyTake-Home Points
by: Michael A. Campos, MD, et al.
Published: (2025-03-01)

Rare variants in alpha 1 antitrypsin deficiency: a systematic literature review
by: Ilaria Ferrarotti, et al.
Published: (2024-02-01)

Alpha-defensins increase NTHi binding but not engulfment by the macrophages enhancing airway inflammation in Alpha-1 antitrypsin deficiency
by: Jungnam Lee, et al.
Published: (2025-02-01)

Case report of a novel alpha1-antitrypsin null variant in Türkiye: Q0RİZE
by: Dilek Karadoğan, et al.
Published: (2024-02-01)

Diagnosis of alpha1-antitrypsin deficiency not just in severe COPD
by: A. Nuñez, et al.
Published: (2018-11-01)

Detection of alpha-1 antitrypsin deficiency: the past, present and future
by: Mark Brantly, et al.
Published: (2020-04-01)

Characterization of alpha-1 antitrypsin in a Pi∗ZZ patient with emphysema: a case report
by: Arturo Olivares Rivera, et al.
Published: (2025-01-01)

Alpha-1-Antitrypsin Deficiency in Children: Case Series
by: Svetlana I. Melnik, et al.
Published: (2016-12-01)

Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications
by: Chapman KR, et al.
Published: (2018-01-01)

Impact of Hypoxia on Neutrophil Degranulation and Inflammatory Response in Alpha-1 Antitrypsin Deficiency Patients
by: María Magallón, et al.
Published: (2024-09-01)

New Pharmacological Tools to Target Leukocyte Trafficking in Lung Disease
by: Kylie B. R. Belchamber, et al.
Published: (2021-07-01)

Alpha-1 antitrypsin deficiency: outstanding questions and future directions
by: María Torres-Durán, et al.
Published: (2018-07-01)

Characteristics associated with SF-36 in alpha-1 antitrypsin deficiency-associated COPD: a cross-sectional analysis
by: Radmila Choate, et al.
Published: (2024-03-01)

Methods of Purification and Application Procedures of Alpha1 Antitrypsin: A Long-Lasting History
by: Simona Viglio, et al.
Published: (2020-09-01)

Description of 22 new alpha-1 antitrypsin genetic variants
by: Céline Renoux, et al.
Published: (2018-09-01)

Alpha-1 Antitrypsin Gene Variants in Patients without Severe Deficiency Diagnosed with Pulmonary Emphysema on Chest CT
by: Laviña E, et al.
Published: (2024-02-01)

Alpha-1 antitrypsin: now available, but do we need it?
by: Swiss Medical Weekly
Published: (2008-04-01)

Alpha-1-antitrypsin deficiency in children: Clinical characteristics and diagnosis
by: Radlović Nedeljko, et al.
Published: (2014-01-01)

Investigating the Link between Alpha-1 Antitrypsin and Human Neutrophil Elastase in Bronchoalveolar Lavage Fluid of COVID-19 Patients
by: Maura D’Amato, et al.
Published: (2022-05-01)

Elevated first-trimester neutrophil elastase and proteinase 3 increase the risk of gestational diabetes mellitus and adverse fetal outcomes
by: Lihong Wang, et al.
Published: (2024-01-01)

Evaluation of the Small Airways in Patients with Chronic Obstructive Pulmonary Disease and Alpha-1 Antitrypsin Deficiency
by: Ferrari da Cruz T, et al.
Published: (2020-09-01)

Developing lung cancer in COPD: Possible role of carrying Alpha-1 antitrypsin deficiency variants
by: Seda Tural Onur, et al.
Published: (2022-01-01)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
by: Sebastian Fähndrich, et al.
Published: (2017-09-01)

The Relationship between Plasma Alpha-1-Antitrypsin Polymers and Lung or Liver Function in ZZ Alpha-1-Antitrypsin-Deficient Patients
by: Annelot D. Sark, et al.
Published: (2022-02-01)

Alpha-1-antitrypsin-deficiency is associated with lower cardiovascular risk: an approach based on federated learning
by: Daniela Zöller, et al.
Published: (2024-01-01)

Portuguese consensus document for the management of alpha-1-antitrypsin deficiency
by: A.P. Lopes, et al.
Published: (2018-12-01)

Alpha-1 Antitrypsin Deficiency and Bronchial Asthma: Current Challenges
by: José Luis Lopez-Campos, et al.
Published: (2025-06-01)

Long-Term SGRQ Stability in a Cohort of Individuals with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease
by: Choate R, et al.
Published: (2024-04-01)